ProQR Therapeutics N.V
ProQR Therapeutics N.V (PRQR) Historical Volatility
PRQR 30-day historical volatility is 60%. This ranks in the 8th percentile of readings over the past year.
Read more
Tracking PRQR historical volatility helps you see how much ProQR Therapeutics N.V's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, ProQR Therapeutics N.V's HV tells you what really happened. Use our scanner to monitor PRQR 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The PRQR 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing ProQR Therapeutics N.V's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in the developing of Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system.
ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands.
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts ProQR Therapeutics N.V's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where PRQR HV is running hot, cold, or in line. Make the PRQR 30 day historical volatility — and every other window — work for your edge instead of against it.
As of September 29, 2026
As of September 29, 2026
See how volatility has moved over time
Track PRQR historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.
Start your 14-day free trial→